Cell & gene therapy in pharma: chimeric antigen receptors

Powered by

Gain invaluable insights that can revolutionize your business


Why settle for outdated information when you can stay ahead of the curve with our comprehensive report?

Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the pharma industry’s chimeric antigen receptors within Cell & gene therapy innovations. By leveraging our report, you’ll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge.

Why Choose Our Report?

Unparalleled Expertise:

Our research team consists of seasoned analysts with deep knowledge and experience in the pharma industry’s chimeric antigen receptors within Cell & gene therapy .We’ve collaborated with leading experts, conducted extensive market research, and carefully curated the most relevant and accurate data to deliver unparalleled insights.

Comprehensive Coverage:

Our report provides a holistic view of the pharma industry’s chimeric antigen receptors landscape, covering a wide range of topics such as product innovations, market dynamics, and future growth prospects. We leave no stone unturned to ensure you have a complete understanding of the market.

Actionable Insights

We go beyond just presenting information; we provide actionable insights that you can implement immediately. Our report highlights the latest innovations driving the chimeric antigen receptors industry and identifies key opportunities for growth, enabling you to make informed decisions and stay one step ahead of your competitors.

Future-proof Strategies:

The pharma industry’s chimeric antigen receptors area within Cell & gene therapy is evolving at a rapid pace. Our report not only helps you understand the current landscape but also equips you with forward-thinking strategies to navigate future challenges and capitalize on emerging trends. Stay future-proof with GlobalData!

Data-driven Analysis:

Our research is grounded in robust data and meticulous analysis. We leverage advanced research methodologies, conduct in-depth interviews, and gather insights from industry leaders to ensure our findings are accurate, reliable, and actionable.


Decode the key disruptive innovations leveraging GlobalData’s innovation s-curve for the pharma sector, with specific focus on chimeric antigen receptors and its trends in patent filing, identifying the leading companies and start-ups (and those with unicorn potential), key application areas plus examples from real-world scenarios and leading countries driving the innovation. In addition, we gauge the adoption trends in chimeric antigen receptors, by analyzing funding/investing trends, demand for human capital/jobs, social media buzz, company filings, and the latest news in the area

Reasons to Buy

  • Identify emerging, accelerating, and maturing innovations in the sector likely to be disruptive in the future
  • Evaluate key companies at the forefront of these innovations and their disruptive impact
  • Discover key start-ups innovating in the area and uncover those with unicorn potential
  • Build strategic technology / product roadmaps to stay ahead of disruption through actionable intelligence

Immatics NV
Bristol-Myers Squibb Co
Memorial Sloan Kettering Cancer Center
Cellectis SA
Gilead Sciences Inc

Table of Contents

Table of Contents

Cell & gene therapy in pharma: chimeric antigen receptors

• Identify key innovations using GlobalData proprietary Innovation S-curves.

• Understand trends in innovation

– trends in patent filing

– leading countries driving the innovation

– % share of innovation across time

• Key players:

– leading companies and their disruptive impact

– start-ups patenting trends

– start-ups with unicorn potential

• Discover real-world innovations

• Decode adoption trends

– analyze trends in funding/ investments

– measure demand for human capital/ jobs

– track social media engagement/ conversations

– understand the company’s strategic focus on innovation

• Deep-dive: key innovating companies

• Appendix

Frequently asked questions

Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Heart Failure Epidemiology Analysis and Forecast to 2032
$3,995 | September 2023
Genomics in pharma: genetic engineered T-cells
$250 | September 2023
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cell & gene therapy in pharma: chimeric antigen receptors in real time.

  • Access a live Cell & gene therapy in pharma: chimeric antigen receptors dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.